Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for ...

Brussels (AFP) | 20/03/2025 - 14:32:33 | Putin must stop 'unnecessary demands' that prolong war, Zelensky tells EU ...

The simple, catheter-based procedure works by restoring the valve’s natural function and promoting favorable left ventricular remodeling. Clinical studies have shown the Carillon therapy reduces ...

Cambridge Study Reveals Virtual Reality as a Game-Changer for Speech AnxietyThe fear of public speaking is widely cited as ...

ZyVersa Therapeutics (ZVSA) highlights newly published animal model data demonstrating that inflammasome inhibition attenuates ...

Discover the hidden ways stress and lifestyle choices are sabotaging your gut health and learn how to restore balance ...

Robust Evidence of Disease Reversal in Severe Knock Out Mice Model Supports Tenaya's Clinical Development Plan to Evaluate TN-201 as a Potential Trea ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) ...

Discover methods to reduce high blood pressure without medication. These natural approaches can help you achieve healthier ...